Interested in maladministration. Estd. 2005
 RTEs Sarah McInerney ? Fianna Fail?supporter? Anthony
Joe Duffy is dishonest and untrustworthy Anthony
Robert Watt complaint: Time for decision by SIPO Anthony
RTE in breach of its own editorial principles Anthony
Waiting for SIPO Anthony Public Inquiry >>
Promoting Human Rights in IrelandHuman Rights in Ireland >>
?I?ve Had It?: JP Morgan Boss Rails Against Gen Z in Expletive-Laden Outburst Sat Feb 15, 2025 15:00 | Will Jones
The boss of JP Morgan, Jamie Dimon, has railed against Gen Z employees who work from home and "bulls**t" bureaucracy at the bank in a leaked recording, saying "I don?t care how many people sign that f***ing petition".
The post “I’ve Had It”: JP Morgan Boss Rails Against Gen Z in Expletive-Laden Outburst appeared first on The Daily Sceptic.
Where Can Lucy Letby Find Justice? Sat Feb 15, 2025 13:00 | Timothy Bradshaw
Former Director of Public Prosecutions Ken MacDonald has said the case against Lucy Letby has been "demolished". But will she find justice in a UK court system battling for its credibility, asks Timothy Bradshaw.
The post Where Can Lucy Letby Find Justice? appeared first on The Daily Sceptic.
Declined: Chapter 8: Locked Out Sat Feb 15, 2025 11:00 | Molly Kingsley
Chapter eight of Declined is here ? a dystopian satire by Molly Kingsley about the emergence of a social credit system in the UK. This week: the moment when the screws tighten to breaking point finally arrives.
The post Declined: Chapter 8: Locked Out appeared first on The Daily Sceptic.
Farmers, is the NFU Really Worth ?36 Million of Your Money Each Year? Sat Feb 15, 2025 09:00 | David Craig
Is the NFU really worth ?36 million of farmers' money each year? David Craig says his experience of trying to get in contact suggests this bloated organisation needs a strong dose of the DOGE treatment.
The post Farmers, is the NFU Really Worth ?36 Million of Your Money Each Year? appeared first on The Daily Sceptic.
Reform Takes Aim at the Green Blob Sat Feb 15, 2025 07:00 | Ben Pile
Reform UK has taken aim at the Green Blob as it "puts the renewables industry on notice". Some have criticised its windfall tax proposal, but Ben Pile says it's smart politics as it will already be scaring away investors.
The post Reform Takes Aim at the Green Blob appeared first on The Daily Sceptic. Lockdown Skeptics >>
Voltaire, international edition
Voltaire, International Newsletter N?120 Fri Feb 14, 2025 13:14 | en
Did the IDF kill more Israelis on October 7, 2023, than the Palestinian resistan... Fri Feb 14, 2025 13:00 | en
Donald Trump and the conflict in Ukraine, by Thierry Meyssan Wed Feb 12, 2025 05:10 | en
Voltaire, International Newsletter N?119 Fri Feb 07, 2025 15:26 | en
Donald Trump plans to displace Palestinians from Gaza and build a riviera on the... Fri Feb 07, 2025 13:33 | en Voltaire Network >>
|
Brazil may break patents in anti-AIDS drive
 international |
consumer issues |
other press
 Tuesday December 07, 2004 14:27 by pat c
The Brazilian government has "threatened" to break the patents on as many as five of the 15 antiretroviral drugs it provides to patients through its National STD/AIDS Programme in order to produce less-expensive generic medicines. Although the Brazilian government over the past three years "repeatedly" has said it might break patent laws in order to negotiate price reductions with pharmaceutical companies, so far it has not done so, according to the Times.
The announcement is a part of the government's national AIDS program, which distributes antiretrovirals at no cost to all HIV-positive people in the country (Colitt, Financial Times, 12/3). The program, which is considered to be one of the most progressive in the world, manufactures and distributes generic versions of antiretrovirals, ignoring patents issued before 1997 when Brazil signed an intellectual property law in order to join the World Trade Organization (Kaiser Daily HIV/AIDS Report, 1/20).
"If we don't move towards self-sufficiency the program will collapse," Pedro Chequer, head of the country's AIDS program, said, adding, "It is not only a legal but above all an ethical commitment" (Financial Times, 12/3).
In January, Brazil's program announced that it had received the largest price reductions on antiretrovirals in five years. The deal was expected to save the treatment program $107 million this year and allow 20,000 new patients to obtain treatment through the program in 2004. The country negotiated deals with drug makers -- including Roche, Gilead and Abbott Laboratories -- generating discounts of between 10% and 76% for the five most expensive antiretroviral medications (Kaiser Daily HIV/AIDS Report, 1/20).
|
printable version
Digg this
del.icio.us
Furl
Reddit
Technorati
Facebook
Gab
Twitter